Fulltext
The full text of this article is available on the PDF file.
Zahedan Journal of Research in Medical Sciences
The Official Journal of Zahedan University of Medical Sciences
Outlines
The comparison of two combination antibiotic [(OAB-T) VS (OAB-F)] regimen trophy in peptic ulcer and dyspepsia patients
Author(s):
1Dept of Internal Medicine, Faculty of Medicine, Zahedan University of Medical Sciences and Health Services, Zahedan, Iran.
2Dept of Pathology, Faculty of Medicine, Zahedan University of Medical Sciences and Health Services, Zahedan, Iran.
*Corresponding Author: Dept of Internal Medicine, Faculty of Medicine, Zahedan University of Medical Sciences and Health Services, Zahedan, Iran. Email: [email protected]
Published online:Oct 10, 2007
Article type:Research Article
Received:Aug 19, 2007
Accepted:Sep 22, 2007
How to Cite:Bahari A, Nezam SK, Karimi M, Firoozeh K. The comparison of two combination antibiotic [(OAB-T) VS (OAB-F)] regimen trophy in peptic ulcer and dyspepsia patients. Zahedan J Res Med Sci. 2007;9(4):e94775. doi:
Abstract
Background: Eradication of H. Pylori has an important role in curing peptic ulcer and
dyspepsia. Several therapeutic regimens have been offered for eradication of H. Pylori. There are
several reports of resistance of H. Pylori to metronidazole in Iran, so other therapeutic regimens
have been offered. We compared Furazolidone versus Tetracycline, in quadruple regimen
[Omeprazole-Amoxicillin-Bismuth subcitrate-Tetracycline (OAB-T) vs. [Omeprazole-Amoxicillin-
Bismuth subcitrate-Furazolidone (OAB-F)].
Materials and Methods: In a clinical trial study we treated 109 H. Pylori infected patients with
dyspepsia in Zahedan Khatam-ol-Anbia Hospital in two therapeutic groups. The first group
received Omeprazole 20 mg BID, Bismuth subcitrate 200 mg Q6h, Amoxicillin 1 gr Q12h,
Furazolidone 100 mg Q12h. The second group received Omeprazole 20 mg BID, Bismuth
subcitrate 200 mg Q6h, Amoxicillin 1 gr Q12h, Tetracycline 500 mg Q 12h.
Results: There were 49 patients in OAB-F group and 51 patients in OAB-T group. H. Pylori
eradication rate based on H. Pylori fecal Ag Test negativity was 85.7% and 80.4% in OAB-F &
OAB-T groups respectively.
Discussion: Furazolidone-based regimen is effective in H. Pylori eradication. With respect to
low price and availability of Furazolidone, Furazolidone- based Quadruple therapy is an
acceptable regimen in communities with high metronidazole resistance.
References
- 1.The References of this article are available on the PDF file.
Copyright
© 2007, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
9
Feb
2021
Comparison of Clarithromycin-based Triple Therapy and Furazolidone-based Quadruple Therapy in Eradicating Helicobacter pylori Infection
Alireza Bakhshipour,
Narges Mohsenpour Mohammadi,
Seyed Mahdi Hashemi,
Mohammad Kazem Momeni
Bakhshipour A, Mohsenpour Mohammadi N, Hashemi SM, Momeni MK. Comparison of Clarithromycin-based Triple Therapy and Furazolidone-based Quadruple Therapy in Eradicating Helicobacter pylori Infection. Int J Infect. 2021;8(1):e98954. doi: https://doi.org/10.5812/iji.98954
30
Apr
2009
Treatment for Helicobacter pylori infection, an overview
Eskandar Hajiani
Hajiani E. Treatment for Helicobacter pylori infection, an overview. Jundishapur J Microbiol. 2009;2(2):. doi:
25
Jun
2014
Furazolidone-Based Quadruple Therapy for Eradication of Helicobacter pylori Infection in Peptic Ulcer Disease
Rahim Raoufi Jahromi,
Jamal Mirzaei,
Jalil Rajabi,
Seyed Javad Hoseini Shokouh,
Taraneh Liaghat
Raoufi Jahromi R, Mirzaei J, Rajabi J, Hoseini Shokouh SJ, Liaghat T. Furazolidone-Based Quadruple Therapy for Eradication of Helicobacter pylori Infection in Peptic Ulcer Disease. Arch Clin Infect Dis. 2014;9(3):e18549. doi: https://doi.org/10.5812/archcid.18549
30
Nov
2008
COMPARISON OF A 10 DAY TRIPLE AND A TWO-WEEK QUADRUPLE THERAPY IN ERADICATING HELICOBACTER PYLORI INFECTION IN PATIENTS REFERRED TO IMAM KHOMEINI HOSPITAL CLINICS AHWAZ, IRAN
E Hajiani,
J Hashemi,
T Vosoghi
Hajiani E, Hashemi J, Vosoghi T. COMPARISON OF A 10 DAY TRIPLE AND A TWO-WEEK QUADRUPLE THERAPY IN ERADICATING HELICOBACTER PYLORI INFECTION IN PATIENTS REFERRED TO IMAM KHOMEINI HOSPITAL CLINICS AHWAZ, IRAN. Jundishapur J Nat Pharm Prod. 2008;3(1):. doi:
19
Jun
2009
A comparative study of eradication of H. pylori infection in dyspepsy patients using a low dose and a high dose triple therapy with clarithromycin, amoxicillin and Omeprazole
Ali Asghar Keshavarz,
Babak Izadi,
Mansour Rezaei,
Amir Shahkarami
Keshavarz AA, Izadi B, Rezaei M, Shahkarami A. A comparative study of eradication of H. pylori infection in dyspepsy patients using a low dose and a high dose triple therapy with clarithromycin, amoxicillin and Omeprazole. J Kermanshah Univ Med Sci. 2009;13(1):e79825. doi:
Download PDF189.19 KB
Comments
Number of Comments:0Cited by
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 0
Last Update: 1 week ago
- CrossRef: 0
Last Update: 5 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Search Relations
Author(s):
Related Articles